From the ∗Department of Internal Medicine II, Gastroenterology
†European Neuroendocrine Tumor Society Center of Excellence, NET Zentrum Würzburg
‡Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
§Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD
∥Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Received for publication November 27, 2022; revision accepted January 26, 2023.
Conflicts of interest and sources of funding: This project is partially supported by the Okayama University “RECTOR” Program (T.H.) and the German Research Foundation (507803309, R.A.W.; 453989101, R.A.W., T.H.). T.H. received a KAKENHI grant (22H03027) from the Japan Society for the Promotion of Science. R.A.W. has received speaker’s honoraria from Novartis and Triple A. The other authors have no conflicts to report.
Correspondence to: Rudolf A. Werner, MD, Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany. E-mail: [email protected].